Suzanne Oparil Selected Research

Myocardial Infarction

11/2021	Sustained SBP control and long-term nursing home admission among Medicare beneficiaries.
1/2021	Association of Sustained Blood Pressure Control with Lower Risk for High-Cost Multimorbidities Among Medicare Beneficiaries in ALLHAT.
1/2021	Worsening Kidney Function Is the Major Mechanism of Heart Failure in Hypertension: The ALLHAT Study.
1/2020	Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults.
1/2020	Race-based and sex-based differences in bioactive lipid mediators after myocardial infarction.
1/2019	Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study.
1/2019	Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT.
1/2018	VEGF nanoparticles repair the heart after myocardial infarction.
11/2017	Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
1/2017	Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suzanne Oparil Research Topics

Disease

187	Hypertension (High Blood Pressure) 03/2024 - 02/2002
47	Myocardial Infarction 11/2021 - 03/2002
34	Stroke (Strokes) 05/2024 - 03/2002
33	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 03/2002
26	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 03/2002
20	Heart Failure 01/2023 - 04/2008
17	Inflammation (Inflammations) 01/2023 - 10/2003
17	Hypoxia (Hypoxemia) 05/2012 - 02/2002
14	Chronic Renal Insufficiency 05/2024 - 05/2003
14	Vascular Remodeling 07/2014 - 02/2002
12	Obesity 11/2022 - 01/2010
11	Neointima 01/2017 - 08/2002
9	Hypertrophy 01/2019 - 05/2003
8	Isolated Systolic Hypertension 12/2022 - 09/2002
8	Diabetes Mellitus 01/2018 - 09/2002
8	Obstructive Sleep Apnea 09/2017 - 03/2009
8	Vascular System Injuries 01/2017 - 01/2004
7	Hyperaldosteronism (Conn Syndrome) 01/2022 - 10/2007
7	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2003
7	Cardiomegaly (Heart Hypertrophy) 12/2013 - 05/2003
6	Weight Loss (Weight Reduction) 11/2022 - 03/2009
5	Neoplasms (Cancer) 06/2023 - 10/2010
5	Fibrosis (Cirrhosis) 01/2023 - 11/2004
5	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 11/2015
5	Chronic Kidney Failure (Chronic Renal Failure) 10/2022 - 05/2009
5	Pulmonary Hypertension 12/2011 - 12/2002
4	Hypotension (Low Blood Pressure) 01/2021 - 11/2015
4	Syncope (Fainting) 01/2021 - 11/2015
4	Prehypertension 01/2021 - 04/2006
4	Albuminuria 01/2019 - 09/2004
4	Insulin Resistance 12/2013 - 11/2005
4	Essential Hypertension 01/2008 - 08/2003
3	Proteinuria 10/2022 - 02/2008
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 11/2005
3	Infarction (Infarctions) 01/2018 - 02/2012

Drug/Important Bio-Agent (IBA)

116	Antihypertensive Agents (Antihypertensives)IBA 05/2024 - 03/2002
32	LipidsIBA 11/2022 - 05/2003
29	DiureticsIBA 10/2022 - 03/2002
27	Amlodipine (Norvasc)FDA LinkGeneric 01/2021 - 09/2006
25	Losartan (Cozaar)FDA LinkGeneric 03/2009 - 03/2002
21	Chlorthalidone (Chlortalidone)FDA LinkGeneric 01/2021 - 09/2006
21	Atenolol (Tenormin)FDA LinkGeneric 11/2013 - 03/2002
19	AldosteroneIBA 01/2021 - 04/2003
17	Angiotensin Receptor AntagonistsIBA 01/2022 - 04/2003
16	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2020 - 01/2005
15	SodiumIBA 01/2022 - 06/2006
15	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 05/2003
15	Lisinopril (Prinivil)FDA LinkGeneric 01/2021 - 09/2006
14	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 05/2003
13	Olmesartan Medoxomil (Votum)FDA Link 01/2020 - 03/2007
13	Atrial Natriuretic Factor (ANF)IBA 10/2011 - 02/2002
11	ReninIBA 01/2017 - 07/2007
10	ThiazidesIBA 11/2020 - 05/2003
10	SaltsIBA 01/2020 - 02/2002
10	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2003
10	Estrogens (Estrogen)FDA Link 07/2015 - 10/2003
9	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 03/2009
9	Messenger RNA (mRNA)IBA 07/2011 - 08/2003
8	Dietary SodiumIBA 01/2020 - 06/2006
8	Valsartan (Vals)FDA Link 01/2017 - 01/2005
8	CollagenIBA 08/2013 - 07/2003
8	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2012 - 02/2006
7	Spironolactone (Aldactone)FDA LinkGeneric 12/2023 - 03/2008
7	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2023 - 12/2003
7	CreatinineIBA 01/2023 - 09/2004
7	aliskiren FDA Link 02/2013 - 07/2007
6	CytokinesIBA 01/2023 - 10/2003
6	salicylhydroxamic acid (SHAM)IBA 10/2022 - 09/2006
6	olmesartanIBA 01/2018 - 01/2008
6	Renin InhibitorsIBA 10/2012 - 09/2007
6	Transforming Growth Factor beta (TGF-beta)IBA 02/2010 - 02/2006
5	PotassiumIBA 10/2018 - 03/2008
5	Interleukin-8 ReceptorsIBA 01/2017 - 03/2012
5	Valsartan Drug Combination Amlodipine FDA Link 01/2014 - 12/2009
5	C-Reactive ProteinIBA 01/2014 - 10/2003
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2013 - 07/2003
5	Endothelin A ReceptorIBA 05/2012 - 12/2002
5	Angiotensin IIIBA 01/2009 - 08/2003
5	N-propionylprocainamideIBA 09/2006 - 05/2003
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2003
4	ElectrolytesIBA 01/2021 - 11/2015
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2009
4	Endothelin-1 (Endothelin 1)IBA 01/2017 - 01/2007
4	BQ 610IBA 05/2012 - 12/2002
4	PeriostinIBA 10/2006 - 07/2003
4	OsteopontinIBA 08/2006 - 08/2002
3	Chemotactic FactorsIBA 01/2023 - 07/2014
3	ChemokinesIBA 01/2023 - 10/2003
3	Doxazosin (Cardura)FDA LinkGeneric 01/2021 - 09/2006
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 09/2005
3	Neprilysin (Neutral Endopeptidase)IBA 01/2019 - 12/2012
3	Interleukin-8 (Interleukin 8)IBA 07/2014 - 03/2012
3	AlbuminsIBA 09/2013 - 09/2004

Therapy/Procedure

58	Therapeutics 06/2023 - 08/2002
12	Denervation 10/2022 - 02/2012
7	Bariatric Surgery 11/2022 - 02/2017
6	Drug Therapy (Chemotherapy) 05/2017 - 11/2005
5	Catheters 10/2022 - 02/2012
4	Ambulatory Care (Outpatient Care) 01/2023 - 01/2019
3	Secondary Prevention 10/2016 - 01/2003